Scope of the Study
Catalpol, an iridoid glucoside, is extensively distributed in many plant families and is mainly obtained from the root of Rehmannia glutinosa Libosch. Rehmannia glutinosa is a plant very usually used in Korean and Chinese traditional medicine for various disorders, including diabetes, neuronal disorders, mellitus, and inflammation. Furthermore, Catalpol has been studied extensively for its biological properties both in vitro and in vivo. It has many pharmacological activities including antiapoptotic, anti-inflammatory and antioxidant functions as well as neuroprotective effects.
The market study is being classified by Type (Purity: 99%, Purity: 96% and Other), by Application (Medicine, Chemical Industry, Additive and Others) and major geographies with country level break-up.
Chengdu Biopurify Phytochemicals Ltd (China), Shanghai Standard Technology (China), Bide Pharmatech Ltd (China), Hangzhou DayangChem (China), AK Scientific (United States), Sigma-Aldrich (United States), Cayman Chemical (United States), Hangzhou Meite Industry Co., Ltd (China), Haihang Industry Co., Ltd. (China) and Xingrui Industry Co., Limited (China) are some of the key players profiled in the study.
The market is highly competitive owing to the presence of several prominent vendors within the industry. Leading players are adopting some organic and inorganic strategies such as merger, acquisition, partnerships, product launch, among others in order to gain leading share within the market. Moreover, some of the players are doing research & development activities in order to find potential benefits of Catalpol in other diseases area. In addition, there are several players are expected to enter within the market during the projected period. Research Analyst at AMA predicts that Chinese Players will contribute to the maximum growth of Global Catalpol market throughout the predicted period.
Segment Analysis
AdvanceMarketAnalytics has segmented the market of Global Catalpol market by Type, Application and Region.
On the basis of geography, the market of Catalpol has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Market Drivers
- The Growing Application of Catalpol in the Medicine Due to Its Potential Benefits
- The Growing Chronic Diseases across the Globe
Market Trend
- The Rising Applications for the Diabetes
Restraints
- There Is No Reported That Catalpol Used As Clinical Drug In The Treatment Of Age-Related Diseases Because Of Its Blood–Brain Barrier Caused By Low Lipophilicity And Fast Metabolism In Body
Opportunities
- The Emerging Demand from Economies
- Ongoing Research & Development Activities
Key Target Audience
Catalpol Manufacturers, Catalpol Raw Material Suppliers, Catalpol Traders/Distributors, Catalpol Importer/Exporter, Regulatory & Government Bodies, End Users and Others
Customization in the Report Available:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase